1 Study Coverage 1.1 Left Ventricular Dysfunction Drug Product Introduction 1.2 Market by Type 1.2.1 Global Left Ventricular Dysfunction Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 BAY-1142524 1.2.3 CAP-1002 1.2.4 Carvedilol CR 1.2.5 CTX-101 1.2.6 Omecamtiv Mecarbil 1.2.7 Others 1.3 Market by Application 1.3.1 Global Left Ventricular Dysfunction Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Left Ventricular Dysfunction Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Left Ventricular Dysfunction Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Left Ventricular Dysfunction Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Left Ventricular Dysfunction Drug Sales by Region 2.4.1 Global Left Ventricular Dysfunction Drug Sales by Region (2017-2022) 2.4.2 Global Sales Left Ventricular Dysfunction Drug by Region (2023-2028) 2.5 Global Left Ventricular Dysfunction Drug Revenue by Region 2.5.1 Global Left Ventricular Dysfunction Drug Revenue by Region (2017-2022) 2.5.2 Global Left Ventricular Dysfunction Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Left Ventricular Dysfunction Drug Sales by Manufacturers 3.1.1 Global Top Left Ventricular Dysfunction Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Left Ventricular Dysfunction Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Left Ventricular Dysfunction Drug in 2021 3.2 Global Left Ventricular Dysfunction Drug Revenue by Manufacturers 3.2.1 Global Left Ventricular Dysfunction Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Left Ventricular Dysfunction Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Left Ventricular Dysfunction Drug Revenue in 2021 3.3 Global Left Ventricular Dysfunction Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Left Ventricular Dysfunction Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Left Ventricular Dysfunction Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Left Ventricular Dysfunction Drug Sales by Type 4.1.1 Global Left Ventricular Dysfunction Drug Historical Sales by Type (2017-2022) 4.1.2 Global Left Ventricular Dysfunction Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) 4.2 Global Left Ventricular Dysfunction Drug Revenue by Type 4.2.1 Global Left Ventricular Dysfunction Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Left Ventricular Dysfunction Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) 4.3 Global Left Ventricular Dysfunction Drug Price by Type 4.3.1 Global Left Ventricular Dysfunction Drug Price by Type (2017-2022) 4.3.2 Global Left Ventricular Dysfunction Drug Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Left Ventricular Dysfunction Drug Sales by Application 5.1.1 Global Left Ventricular Dysfunction Drug Historical Sales by Application (2017-2022) 5.1.2 Global Left Ventricular Dysfunction Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) 5.2 Global Left Ventricular Dysfunction Drug Revenue by Application 5.2.1 Global Left Ventricular Dysfunction Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Left Ventricular Dysfunction Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) 5.3 Global Left Ventricular Dysfunction Drug Price by Application 5.3.1 Global Left Ventricular Dysfunction Drug Price by Application (2017-2022) 5.3.2 Global Left Ventricular Dysfunction Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Left Ventricular Dysfunction Drug Market Size by Type 6.1.1 North America Left Ventricular Dysfunction Drug Sales by Type (2017-2028) 6.1.2 North America Left Ventricular Dysfunction Drug Revenue by Type (2017-2028) 6.2 North America Left Ventricular Dysfunction Drug Market Size by Application 6.2.1 North America Left Ventricular Dysfunction Drug Sales by Application (2017-2028) 6.2.2 North America Left Ventricular Dysfunction Drug Revenue by Application (2017-2028) 6.3 North America Left Ventricular Dysfunction Drug Market Size by Country 6.3.1 North America Left Ventricular Dysfunction Drug Sales by Country (2017-2028) 6.3.2 North America Left Ventricular Dysfunction Drug Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Left Ventricular Dysfunction Drug Market Size by Type 7.1.1 Europe Left Ventricular Dysfunction Drug Sales by Type (2017-2028) 7.1.2 Europe Left Ventricular Dysfunction Drug Revenue by Type (2017-2028) 7.2 Europe Left Ventricular Dysfunction Drug Market Size by Application 7.2.1 Europe Left Ventricular Dysfunction Drug Sales by Application (2017-2028) 7.2.2 Europe Left Ventricular Dysfunction Drug Revenue by Application (2017-2028) 7.3 Europe Left Ventricular Dysfunction Drug Market Size by Country 7.3.1 Europe Left Ventricular Dysfunction Drug Sales by Country (2017-2028) 7.3.2 Europe Left Ventricular Dysfunction Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Left Ventricular Dysfunction Drug Market Size by Type 8.1.1 Asia Pacific Left Ventricular Dysfunction Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Left Ventricular Dysfunction Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Left Ventricular Dysfunction Drug Market Size by Application 8.2.1 Asia Pacific Left Ventricular Dysfunction Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Left Ventricular Dysfunction Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Left Ventricular Dysfunction Drug Market Size by Region 8.3.1 Asia Pacific Left Ventricular Dysfunction Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Left Ventricular Dysfunction Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Left Ventricular Dysfunction Drug Market Size by Type 9.1.1 Latin America Left Ventricular Dysfunction Drug Sales by Type (2017-2028) 9.1.2 Latin America Left Ventricular Dysfunction Drug Revenue by Type (2017-2028) 9.2 Latin America Left Ventricular Dysfunction Drug Market Size by Application 9.2.1 Latin America Left Ventricular Dysfunction Drug Sales by Application (2017-2028) 9.2.2 Latin America Left Ventricular Dysfunction Drug Revenue by Application (2017-2028) 9.3 Latin America Left Ventricular Dysfunction Drug Market Size by Country 9.3.1 Latin America Left Ventricular Dysfunction Drug Sales by Country (2017-2028) 9.3.2 Latin America Left Ventricular Dysfunction Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Left Ventricular Dysfunction Drug Market Size by Type 10.1.1 Middle East and Africa Left Ventricular Dysfunction Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Left Ventricular Dysfunction Drug Market Size by Application 10.2.1 Middle East and Africa Left Ventricular Dysfunction Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Left Ventricular Dysfunction Drug Market Size by Country 10.3.1 Middle East and Africa Left Ventricular Dysfunction Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Bayer AG 11.1.1 Bayer AG Corporation Information 11.1.2 Bayer AG Overview 11.1.3 Bayer AG Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Bayer AG Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Bayer AG Recent Developments 11.2 Innopharmax Inc 11.2.1 Innopharmax Inc Corporation Information 11.2.2 Innopharmax Inc Overview 11.2.3 Innopharmax Inc Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Innopharmax Inc Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Innopharmax Inc Recent Developments 11.3 Mesoblast Ltd 11.3.1 Mesoblast Ltd Corporation Information 11.3.2 Mesoblast Ltd Overview 11.3.3 Mesoblast Ltd Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Mesoblast Ltd Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Mesoblast Ltd Recent Developments 11.4 Novartis AG 11.4.1 Novartis AG Corporation Information 11.4.2 Novartis AG Overview 11.4.3 Novartis AG Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Novartis AG Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Novartis AG Recent Developments 11.5 Quantum Genomics SA 11.5.1 Quantum Genomics SA Corporation Information 11.5.2 Quantum Genomics SA Overview 11.5.3 Quantum Genomics SA Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Quantum Genomics SA Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Quantum Genomics SA Recent Developments 11.6 TiGenix NV 11.6.1 TiGenix NV Corporation Information 11.6.2 TiGenix NV Overview 11.6.3 TiGenix NV Left Ventricular Dysfunction Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 TiGenix NV Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 TiGenix NV Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Left Ventricular Dysfunction Drug Industry Chain Analysis 12.2 Left Ventricular Dysfunction Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Left Ventricular Dysfunction Drug Production Mode & Process 12.4 Left Ventricular Dysfunction Drug Sales and Marketing 12.4.1 Left Ventricular Dysfunction Drug Sales Channels 12.4.2 Left Ventricular Dysfunction Drug Distributors 12.5 Left Ventricular Dysfunction Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Left Ventricular Dysfunction Drug Industry Trends 13.2 Left Ventricular Dysfunction Drug Market Drivers 13.3 Left Ventricular Dysfunction Drug Market Challenges 13.4 Left Ventricular Dysfunction Drug Market Restraints 14 Key Findings in The Global Left Ventricular Dysfunction Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Left Ventricular Dysfunction Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of BAY-1142524 Table 3. Major Manufacturers of CAP-1002 Table 4. Major Manufacturers of Carvedilol CR Table 5. Major Manufacturers of CTX-101 Table 6. Major Manufacturers of Omecamtiv Mecarbil Table 7. Major Manufacturers of Others Table 8. Global Left Ventricular Dysfunction Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Left Ventricular Dysfunction Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 10. Global Left Ventricular Dysfunction Drug Sales by Region (2017-2022) & (K Pcs) Table 11. Global Left Ventricular Dysfunction Drug Sales Market Share by Region (2017-2022) Table 12. Global Left Ventricular Dysfunction Drug Sales by Region (2023-2028) & (K Pcs) Table 13. Global Left Ventricular Dysfunction Drug Sales Market Share by Region (2023-2028) Table 14. Global Left Ventricular Dysfunction Drug Revenue by Region (2017-2022) & (US$ Million) Table 15. Global Left Ventricular Dysfunction Drug Revenue Market Share by Region (2017-2022) Table 16. Global Left Ventricular Dysfunction Drug Revenue by Region (2023-2028) & (US$ Million) Table 17. Global Left Ventricular Dysfunction Drug Revenue Market Share by Region (2023-2028) Table 18. Global Left Ventricular Dysfunction Drug Sales by Manufacturers (2017-2022) & (K Pcs) Table 19. Global Left Ventricular Dysfunction Drug Sales Share by Manufacturers (2017-2022) Table 20. Global Left Ventricular Dysfunction Drug Revenue by Manufacturers (2017-2022) & (US$ Million) Table 21. Global Left Ventricular Dysfunction Drug Revenue Share by Manufacturers (2017-2022) Table 22. Left Ventricular Dysfunction Drug Price by Manufacturers (2017-2022) &(USD/Pcs) Table 23. Global Left Ventricular Dysfunction Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Left Ventricular Dysfunction Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Dysfunction Drug as of 2021) Table 25. Left Ventricular Dysfunction Drug Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Left Ventricular Dysfunction Drug Product Offered Table 27. Date of Manufacturers Enter into Left Ventricular Dysfunction Drug Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 30. Global Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 31. Global Left Ventricular Dysfunction Drug Sales Share by Type (2017-2022) Table 32. Global Left Ventricular Dysfunction Drug Sales Share by Type (2023-2028) Table 33. Global Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 34. Global Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 35. Global Left Ventricular Dysfunction Drug Revenue Share by Type (2017-2022) Table 36. Global Left Ventricular Dysfunction Drug Revenue Share by Type (2023-2028) Table 37. Left Ventricular Dysfunction Drug Price by Type (2017-2022) & (USD/Pcs) Table 38. Global Left Ventricular Dysfunction Drug Price Forecast by Type (2023-2028) & (USD/Pcs) Table 39. Global Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 40. Global Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 41. Global Left Ventricular Dysfunction Drug Sales Share by Application (2017-2022) Table 42. Global Left Ventricular Dysfunction Drug Sales Share by Application (2023-2028) Table 43. Global Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 44. Global Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 45. Global Left Ventricular Dysfunction Drug Revenue Share by Application (2017-2022) Table 46. Global Left Ventricular Dysfunction Drug Revenue Share by Application (2023-2028) Table 47. Left Ventricular Dysfunction Drug Price by Application (2017-2022) & (USD/Pcs) Table 48. Global Left Ventricular Dysfunction Drug Price Forecast by Application (2023-2028) & (USD/Pcs) Table 49. North America Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 50. North America Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 51. North America Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 52. North America Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 53. North America Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 54. North America Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 55. North America Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 56. North America Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 57. North America Left Ventricular Dysfunction Drug Sales by Country (2017-2022) & (K Pcs) Table 58. North America Left Ventricular Dysfunction Drug Sales by Country (2023-2028) & (K Pcs) Table 59. North America Left Ventricular Dysfunction Drug Revenue by Country (2017-2022) & (US$ Million) Table 60. North America Left Ventricular Dysfunction Drug Revenue by Country (2023-2028) & (US$ Million) Table 61. Europe Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 62. Europe Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 63. Europe Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 64. Europe Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 65. Europe Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 66. Europe Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 67. Europe Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 68. Europe Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 69. Europe Left Ventricular Dysfunction Drug Sales by Country (2017-2022) & (K Pcs) Table 70. Europe Left Ventricular Dysfunction Drug Sales by Country (2023-2028) & (K Pcs) Table 71. Europe Left Ventricular Dysfunction Drug Revenue by Country (2017-2022) & (US$ Million) Table 72. Europe Left Ventricular Dysfunction Drug Revenue by Country (2023-2028) & (US$ Million) Table 73. Asia Pacific Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 74. Asia Pacific Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 75. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 76. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 77. Asia Pacific Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 78. Asia Pacific Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 79. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 80. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 81. Asia Pacific Left Ventricular Dysfunction Drug Sales by Region (2017-2022) & (K Pcs) Table 82. Asia Pacific Left Ventricular Dysfunction Drug Sales by Region (2023-2028) & (K Pcs) Table 83. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Region (2017-2022) & (US$ Million) Table 84. Asia Pacific Left Ventricular Dysfunction Drug Revenue by Region (2023-2028) & (US$ Million) Table 85. Latin America Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 86. Latin America Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 87. Latin America Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 88. Latin America Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 89. Latin America Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 90. Latin America Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 91. Latin America Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 92. Latin America Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 93. Latin America Left Ventricular Dysfunction Drug Sales by Country (2017-2022) & (K Pcs) Table 94. Latin America Left Ventricular Dysfunction Drug Sales by Country (2023-2028) & (K Pcs) Table 95. Latin America Left Ventricular Dysfunction Drug Revenue by Country (2017-2022) & (US$ Million) Table 96. Latin America Left Ventricular Dysfunction Drug Revenue by Country (2023-2028) & (US$ Million) Table 97. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Type (2017-2022) & (K Pcs) Table 98. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Type (2023-2028) & (K Pcs) Table 99. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Type (2017-2022) & (US$ Million) Table 100. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Type (2023-2028) & (US$ Million) Table 101. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Application (2017-2022) & (K Pcs) Table 102. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Application (2023-2028) & (K Pcs) Table 103. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Application (2017-2022) & (US$ Million) Table 104. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Application (2023-2028) & (US$ Million) Table 105. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Country (2017-2022) & (K Pcs) Table 106. Middle East and Africa Left Ventricular Dysfunction Drug Sales by Country (2023-2028) & (K Pcs) Table 107. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Country (2017-2022) & (US$ Million) Table 108. Middle East and Africa Left Ventricular Dysfunction Drug Revenue by Country (2023-2028) & (US$ Million) Table 109. Bayer AG Corporation Information Table 110. Bayer AG Description and Major Businesses Table 111. Bayer AG Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 112. Bayer AG Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 113. Bayer AG Recent Developments Table 114. Innopharmax Inc Corporation Information Table 115. Innopharmax Inc Description and Major Businesses Table 116. Innopharmax Inc Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 117. Innopharmax Inc Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 118. Innopharmax Inc Recent Developments Table 119. Mesoblast Ltd Corporation Information Table 120. Mesoblast Ltd Description and Major Businesses Table 121. Mesoblast Ltd Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 122. Mesoblast Ltd Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 123. Mesoblast Ltd Recent Developments Table 124. Novartis AG Corporation Information Table 125. Novartis AG Description and Major Businesses Table 126. Novartis AG Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 127. Novartis AG Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 128. Novartis AG Recent Developments Table 129. Quantum Genomics SA Corporation Information Table 130. Quantum Genomics SA Description and Major Businesses Table 131. Quantum Genomics SA Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 132. Quantum Genomics SA Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 133. Quantum Genomics SA Recent Developments Table 134. TiGenix NV Corporation Information Table 135. TiGenix NV Description and Major Businesses Table 136. TiGenix NV Left Ventricular Dysfunction Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 137. TiGenix NV Left Ventricular Dysfunction Drug Product Model Numbers, Pictures, Descriptions and Specifications Table 138. TiGenix NV Recent Developments Table 139. Key Raw Materials Lists Table 140. Raw Materials Key Suppliers Lists Table 141. Left Ventricular Dysfunction Drug Distributors List Table 142. Left Ventricular Dysfunction Drug Customers List Table 143. Left Ventricular Dysfunction Drug Market Trends Table 144. Left Ventricular Dysfunction Drug Market Drivers Table 145. Left Ventricular Dysfunction Drug Market Challenges Table 146. Left Ventricular Dysfunction Drug Market Restraints Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Left Ventricular Dysfunction Drug Product Picture Figure 3. Global Left Ventricular Dysfunction Drug Market Share by Type in 2021 & 2028 Figure 3. BAY-1142524 Product Picture Figure 4. CAP-1002 Product Picture Figure 5. Carvedilol CR Product Picture Figure 6. CTX-101 Product Picture Figure 7. Omecamtiv Mecarbil Product Picture Figure 8. Others Product Picture Figure 9. Global Left Ventricular Dysfunction Drug Market Share by Application in 2021 & 2028 Figure 10. Hospital Figure 11. Clinic Figure 12. Others Figure 13. Left Ventricular Dysfunction Drug Report Years Considered Figure 14. Global Left Ventricular Dysfunction Drug Sales 2017-2028 (K Pcs) Figure 15. Global Left Ventricular Dysfunction Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Left Ventricular Dysfunction Drug Revenue 2017-2028 (US$ Million) Figure 17. Global Left Ventricular Dysfunction Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 18. Global Left Ventricular Dysfunction Drug Sales Market Share by Region (2017-2022) Figure 19. Global Left Ventricular Dysfunction Drug Sales Market Share by Region (2023-2028) Figure 20. North America Left Ventricular Dysfunction Drug Sales YoY (2017-2028) & (K Pcs) Figure 21. North America Left Ventricular Dysfunction Drug Revenue YoY (2017-2028) & (US$ Million) Figure 22. Europe Left Ventricular Dysfunction Drug Sales YoY (2017-2028) & (K Pcs) Figure 23. Europe Left Ventricular Dysfunction Drug Revenue YoY (2017-2028) & (US$ Million) Figure 24. Asia-Pacific Left Ventricular Dysfunction Drug Sales YoY (2017-2028) & (K Pcs) Figure 25. Asia-Pacific Left Ventricular Dysfunction Drug Revenue YoY (2017-2028) & (US$ Million) Figure 26. Latin America Left Ventricular Dysfunction Drug Sales YoY (2017-2028) & (K Pcs) Figure 27. Latin America Left Ventricular Dysfunction Drug Revenue YoY (2017-2028) & (US$ Million) Figure 28. Middle East & Africa Left Ventricular Dysfunction Drug Sales YoY (2017-2028) & (K Pcs) Figure 29. Middle East & Africa Left Ventricular Dysfunction Drug Revenue YoY (2017-2028) & (US$ Million) Figure 30. The Left Ventricular Dysfunction Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 31. The Top 5 and 10 Largest Manufacturers of Left Ventricular Dysfunction Drug in the World: Market Share by Left Ventricular Dysfunction Drug Revenue in 2021 Figure 32. Global Left Ventricular Dysfunction Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 33. Global Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 34. Global Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 35. Global Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 36. Global Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 37. North America Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 38. North America Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 39. North America Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 40. North America Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 41. North America Left Ventricular Dysfunction Drug Sales Share by Country (2017-2028) Figure 42. North America Left Ventricular Dysfunction Drug Revenue Share by Country (2017-2028) Figure 43. U.S. Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 44. Canada Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 45. Europe Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 46. Europe Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 47. Europe Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 48. Europe Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 49. Europe Left Ventricular Dysfunction Drug Sales Share by Country (2017-2028) Figure 50. Europe Left Ventricular Dysfunction Drug Revenue Share by Country (2017-2028) Figure 51. Germany Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 52. France Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 53. U.K. Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 54. Italy Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 55. Russia Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 56. Asia Pacific Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 57. Asia Pacific Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 58. Asia Pacific Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 59. Asia Pacific Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 60. Asia Pacific Left Ventricular Dysfunction Drug Sales Share by Region (2017-2028) Figure 61. Asia Pacific Left Ventricular Dysfunction Drug Revenue Share by Region (2017-2028) Figure 62. China Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 63. Japan Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 64. South Korea Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 65. India Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 66. Australia Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 67. Taiwan Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 68. Indonesia Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 69. Thailand Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 70. Malaysia Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 71. Philippines Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 72. Latin America Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 73. Latin America Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 74. Latin America Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 75. Latin America Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 76. Latin America Left Ventricular Dysfunction Drug Sales Share by Country (2017-2028) Figure 77. Latin America Left Ventricular Dysfunction Drug Revenue Share by Country (2017-2028) Figure 78. Mexico Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 79. Brazil Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 80. Argentina Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 81. Middle East and Africa Left Ventricular Dysfunction Drug Sales Market Share by Type (2017-2028) Figure 82. Middle East and Africa Left Ventricular Dysfunction Drug Revenue Market Share by Type (2017-2028) Figure 83. Middle East and Africa Left Ventricular Dysfunction Drug Sales Market Share by Application (2017-2028) Figure 84. Middle East and Africa Left Ventricular Dysfunction Drug Revenue Market Share by Application (2017-2028) Figure 85. Middle East and Africa Left Ventricular Dysfunction Drug Sales Share by Country (2017-2028) Figure 86. Middle East and Africa Left Ventricular Dysfunction Drug Revenue Share by Country (2017-2028) Figure 87. Turkey Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 88. Saudi Arabia Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 89. U.A.E Left Ventricular Dysfunction Drug Revenue (2017-2028) & (US$ Million) Figure 90. Left Ventricular Dysfunction Drug Value Chain Figure 91. Left Ventricular Dysfunction Drug Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV